Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie R Brahmer

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Annals of Internal Medicine|October 19, 2005
Update in oncologyJulie R Brahmer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Harnessing the immune system for the treatment of non-small-cell lung cancerJulie R Brahmer
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Identifying and addressing the toxicity of checkpoint inhibitors in lung cancerJulie R Brahmer
Clinical Advances in Hematology & Oncology : H&O|November 29, 2012
PD-1-targeted immunotherapy: recent clinical findingsJulie R Brahmer
Seminars in Oncology|February 26, 2014
Immune checkpoint blockade: the hope for immunotherapy as a treatment of lung cancer?Julie R Brahmer
The New England Journal of Medicine|March 9, 2017
Pembrolizumab in Non-Small-Cell Lung CancerMartin Reck, Julie R Brahmer
Current Treatment Options in Oncology|August 13, 2013
Targeting the immune system in the treatment of non-small-cell lung cancerDeepa Rangachari, Julie R Brahmer
Cancer Journal (Sudbury, Mass.)|April 26, 2016
Immune Checkpoint Therapy in Non-Small Cell Lung CancerKristen A Marrone, Julie R Brahmer
Journal of the National Comprehensive Cancer Network : JNCCN|July 4, 2006
Adjuvant treatment in non-small cell lung cancer: Where are we now?Rosalyn A Juergens, Julie R Brahmer
Cancer Investigation|April 8, 2011
Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancerSusanna V Ulahannan, Julie R Brahmer
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Annals of Internal Medicine|October 19, 2005
Update in oncologyJulie R Brahmer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Harnessing the immune system for the treatment of non-small-cell lung cancerJulie R Brahmer
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Identifying and addressing the toxicity of checkpoint inhibitors in lung cancerJulie R Brahmer
Clinical Advances in Hematology & Oncology : H&O|November 29, 2012
PD-1-targeted immunotherapy: recent clinical findingsJulie R Brahmer
Seminars in Oncology|February 26, 2014
Immune checkpoint blockade: the hope for immunotherapy as a treatment of lung cancer?Julie R Brahmer
The New England Journal of Medicine|March 9, 2017
Pembrolizumab in Non-Small-Cell Lung CancerMartin Reck, Julie R Brahmer
Current Treatment Options in Oncology|August 13, 2013
Targeting the immune system in the treatment of non-small-cell lung cancerDeepa Rangachari, Julie R Brahmer
Cancer Journal (Sudbury, Mass.)|April 26, 2016
Immune Checkpoint Therapy in Non-Small Cell Lung CancerKristen A Marrone, Julie R Brahmer
Journal of the National Comprehensive Cancer Network : JNCCN|July 4, 2006
Adjuvant treatment in non-small cell lung cancer: Where are we now?Rosalyn A Juergens, Julie R Brahmer
Cancer Investigation|April 8, 2011
Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancerSusanna V Ulahannan, Julie R Brahmer
Pageof 20